Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
Charles River Laboratories (NYSE: CRL) has announced its upcoming presentation at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14th, at 2:15 p.m. PT (5:15 p.m. ET). The presentation will feature management's overview of the company's strategic focus, business developments, and recent trends.
Investors and interested parties can access a live webcast of the presentation through a link that will be available on the Investor Relations section of Charles River's website at ir.criver.com. A replay of the webcast will be accessible through the same website following the presentation and will remain available for a minimum of two weeks.
Charles River Laboratories (NYSE: CRL) ha annunciato la sua prossima presentazione alla 43ª Conferenza Annuale J.P. Morgan Healthcare che si terrà martedì 14 gennaio, alle 14:15 PT (17:15 ET). La presentazione includerà una panoramica della gestione sul focalizzazione strategica, sugli sviluppi aziendali e sulle tendenze recenti.
Investitori e parti interessate possono accedere a un webcast in diretta della presentazione tramite un link che sarà disponibile nella sezione Relazioni con gli Investitori del sito web di Charles River all'indirizzo ir.criver.com. Una registrazione del webcast sarà accessibile tramite lo stesso sito dopo la presentazione e rimarrà disponibile per un minimo di due settimane.
Charles River Laboratories (NYSE: CRL) ha anunciado su próxima presentación en la 43ª Conferencia Anual de Salud J.P. Morgan el martes 14 de enero a las 2:15 p.m. PT (5:15 p.m. ET). La presentación incluirá una visión general de la gestión sobre el enfoque estratégico, los desarrollos comerciales y las tendencias recientes.
Los inversores y partes interesadas podrán acceder a un webcast en vivo de la presentación a través de un enlace que estará disponible en la sección de Relaciones con los Inversores del sitio web de Charles River en ir.criver.com. Una repetición del webcast estará accesible a través del mismo sitio tras la presentación y permanecerá disponible durante un mínimo de dos semanas.
찰스 리버 랩스 (NYSE: CRL)는 제43회 연례 JP 모건 헬스케어 컨퍼런스에서 발표할 예정임을 발표했습니다. 발표는 1월 14일 화요일 오후 2:15 PT (오후 5:15 ET)에 진행됩니다. 발표에서는 회사의 전략적 초점, 비즈니스 개발 및 최근 동향에 대한 경영진의 개요가 포함될 것입니다.
투자자 및 이해관계자는 찰스 리버 웹사이트의 투자자 관계 섹션(ir.criver.com)에 있는 링크를 통해 실시간 웹캐스트를 통해 발표를 시청할 수 있습니다. 발표 후 동일한 웹사이트를 통해 웹캐스트 재생이 가능하며 최소 2주간 이용 가능합니다.
Charles River Laboratories (NYSE: CRL) a annoncé sa prochaine présentation à la 43e Conférence Annuelle J.P. Morgan Healthcare prévue pour le mardi 14 janvier à 14h15 PT (17h15 ET). Cette présentation comprendra un aperçu du management concernant le focus stratégique, les développements commerciaux et les tendances récentes.
Les investisseurs et parties intéressées peuvent accéder à un webinaire en direct de la présentation via un lien qui sera disponible dans la section Relations Investisseurs du site web de Charles River à l'adresse ir.criver.com. Une rediffusion du webinaire sera accessible sur le même site après la présentation et restera disponible pendant au moins deux semaines.
Charles River Laboratories (NYSE: CRL) hat seine bevorstehende Präsentation auf der 43. Jahreskonferenz von J.P. Morgan Healthcare für Dienstag, den 14. Januar, um 14:15 Uhr PT (17:15 Uhr ET) angekündigt. Die Präsentation wird einen Überblick des Managements über den strategischen Fokus, die Geschäftsentwicklungen und aktuellen Trends bieten.
Investoren und Interessierte können über einen Link, der im Bereich Investor Relations der Charles River-Website unter ir.criver.com verfügbar sein wird, auf einen Live-Webcast der Präsentation zugreifen. Eine Wiederholung des Webcasts wird nach der Präsentation über dieselbe Website verfügbar sein und mindestens zwei Wochen lang abrufbar bleiben.
- None.
- None.
A live webcast of the presentation will be available through a link that will be posted on the Investor Relations section of the Charles River website at ir.criver.com. A webcast replay will be accessible through the same website after the presentation and will remain available for at least two weeks.
About Charles River
Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250113962376/en/
Investor Relations:
Todd Spencer
Corporate Vice President, Investor Relations
781.222.6455
todd.spencer@crl.com
Source: Charles River Laboratories International, Inc.
FAQ
When is Charles River Laboratories (CRL) presenting at the J.P. Morgan Healthcare Conference?
How can investors watch Charles River's (CRL) J.P. Morgan Healthcare Conference presentation?
How long will the replay of CRL's J.P. Morgan Healthcare Conference presentation be available?
What topics will be covered in Charles River's (CRL) J.P. Morgan Healthcare Conference presentation?
